Publications:

Distinctive genomic characteristics in POLE/POLD1-mutant cancers can potentially predict beneficial clinical outcomes in patients who receive immune checkpoint inhibitor.

Annals Of Translational Medicine

He, Junjun J; Ouyang, Wei W; Zhao, Wugan W; Shao, Lin L; Li, Bing B; Liu, Bihao B; Wang, Dejuan D; Han-Zhang, Han H; Zhang, Zhou Z; Shao, Liang L; Li, Wencai W

Publication Date: 2021-01

Variant appearance in text: POLE: 1473+1G>T

PubMed Link: 33569431

Variant Present in the following documents:

• Main text
• atm-09-02-129.pdf

View BVdb publication page